Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia

202516 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov Identifier: NCT05952869.

Published in: JAMA

Volume 335, Issue 2, pp. 129-129

Field-Weighted Citation Impact: 31.31